Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New Biotherapies

Publisher： Karger

E-ISSN： 1423-0194|89|3|308-314

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.89, Iss.3, 2009-03, pp. : 308-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of Somatostatin Receptors 1-5 and Dopamine Receptor 2 in Lung Carcinoids: Implications for a Therapeutic Role

By  

Neuroendocrinology, Vol. 101, Iss. 3, 2015-02 ,pp. : 211-222

Karger

Access to resources Recommend Favorite

Quantitative Gene Expression of Somatostatin Receptors and Noradrenaline Transporter Underlying Scintigraphic Results in Patients with Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 87, Iss. 4, 2008-01 ,pp. : 223-232

Karger

Access to resources Recommend Favorite

Somatostatin and Dopamine-Somatostatin Multiple Ligands Directed towards Somatostatin and Dopamine Receptors in Pituitary Adenomas

By  

Neuroendocrinology, Vol. 83, Iss. 3-4, 2006-10 ,pp. : 258-263

Karger

Access to resources Recommend Favorite

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2016-02 ,pp. : 815-825

Karger

Access to resources Recommend Favorite

The Novel WHO 2010 Classification for Gastrointestinal Neuroendocrine Tumours Correlates Well with the Metastatic Potential of Rectal Neuroendocrine Tumours

By  

Neuroendocrinology, Vol. 95, Iss. 4, 2012-02 ,pp. : 317-324

Karger

Access to resources Recommend Favorite